Regulation of SCI-induced pain by macrophages and exercise

巨噬细胞和运动对 SCI 引起的疼痛的调节

基本信息

  • 批准号:
    10736378
  • 负责人:
  • 金额:
    $ 44.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-18 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Spinal cord injury (SCI) impairs sensory transmission and leads to chronic, debilitating neuropathic pain. Chronic pain afflicts over 100 million Americans and creates an enormous burden on US health care systems, costing over half a trillion dollars annually according to a recent report from the Institute of Medicine. While our understanding of the molecular basis underlying the development of chronic pain has improved, the available therapeutics provide limited relief. While our lab and others have shown that early post-SCI rehab can prevent pain development, early rehab in human SCI may not be possible due to the multisystem, polytraumatic injuries individuals with SCI sustain. Thus, there is a critical need for an adjuvant therapy to aid those individuals who are unable to participate in early rehab. Neuropathic pain is increasingly recognized as a neuroimmune disorder. While macrophages are regarded as key regulators of chronic pain development, it is unclear whether they are acting in an inflammatory or reparative manner. This R01 seeks to better understand how or if the activation state of macrophages influences nociceptive neuron excitability and pain development after SCI. We will utilize an established spinal cord injury model of neuropathic pain development and drive macrophage activation state by post-injury rehab, intrathecal administration of exosomes derived from Raw 264.7 macrophages stimulated in vitro or a phosphodiesterase 4 inhibitor by a polymer nanodelivery system that specifically targets macrophages. This proposal seeks to understand the role of macrophages that infiltrate the dorsal root ganglia and persist there chronically after SCI both in the development and maintenance of chronic neuropathic pain.
项目概要 脊髓损伤 (SCI) 会损害感觉传递并导致慢性、衰弱性神经病 疼痛。慢性疼痛困扰着超过一亿美国人,给美国医疗保健造成巨大负担 根据医学研究所最近的一份报告,该系统每年花费超过 5000 亿美元。 虽然我们对慢性疼痛发展的分子基础的了解有所提高,但 现有的治疗方法只能提供有限的缓解。虽然我们的实验室和其他实验室已经表明,脊髓损伤后早期康复 可以预防疼痛的发展,由于多系统,人类 SCI 的早期康复可能是不可能的, 患有 SCI 的人会遭受多发性损伤。因此,迫切需要辅助治疗来帮助 那些无法参加早期康复的人。神经性疼痛越来越被认为是一种 神经免疫紊乱。虽然巨噬细胞被认为是慢性疼痛发展的关键调节因子,但它 尚不清楚它们是否以炎症或修复方式起作用。此 R01 旨在更好地理解 巨噬细胞的激活状态如何或是否影响伤害感受神经元的兴奋性和疼痛的发展 SCI之后。我们将利用已建立的神经性疼痛发展和驱动的脊髓损伤模型 通过损伤后康复、鞘内注射源自 Raw 的外泌体来激活巨噬细胞 264.7 通过聚合物纳米递送系统体外刺激巨噬细胞或磷酸二酯酶 4 抑制剂 专门针对巨噬细胞。该提案旨在了解巨噬细胞渗透的作用 背根神经节并在 SCI 后长期存在于该处,以发展和维持 慢性神经性疼痛。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Modelling at-level allodynia after mid-thoracic contusion in the rat.
  • DOI:
    10.1002/ejp.1711
  • 发表时间:
    2021-04
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Blumenthal GH;Nandakumar B;Schnider AK;Detloff MR;Ricard J;Bethea JR;Moxon KA
  • 通讯作者:
    Moxon KA
Plasticity in Cervical Motor Circuits following Spinal Cord Injury and Rehabilitation.
  • DOI:
    10.3390/biology10100976
  • 发表时间:
    2021-09-28
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Walker JR;Detloff MR
  • 通讯作者:
    Detloff MR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MEGAN R DETLOFF其他文献

MEGAN R DETLOFF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MEGAN R DETLOFF', 18)}}的其他基金

Validation of Prenatal Rabbit Hypoxia Ischemia as a Model of Cerebral Palsy-induced Pain
产前兔缺氧缺血作为脑瘫引起的疼痛模型的验证
  • 批准号:
    10813313
  • 财政年份:
    2023
  • 资助金额:
    $ 44.26万
  • 项目类别:
Regulation of neuropathic pain by exercise: effects on nociceptor plasticity and inflammation
通过运动调节神经性疼痛:对伤害感受器可塑性和炎症的影响
  • 批准号:
    9382617
  • 财政年份:
    2017
  • 资助金额:
    $ 44.26万
  • 项目类别:
Regulation of neuropathic pain by exercise: effects on nociceptor plasticity and inflammation
通过运动调节神经性疼痛:对伤害感受器可塑性和炎症的影响
  • 批准号:
    10226015
  • 财政年份:
    2017
  • 资助金额:
    $ 44.26万
  • 项目类别:
Validation of Targeting Macrophage-Mediated Events in the DRG to Alleviate Chronic Spinal Cord Injury Pain
验证靶向 DRG 中巨噬细胞介导的事件以减轻慢性脊髓损伤疼痛
  • 批准号:
    9816362
  • 财政年份:
    2017
  • 资助金额:
    $ 44.26万
  • 项目类别:
Neuronal plasticity at remote sites causes neuropathic pain after SCI
远端部位的神经元可塑性导致 SCI 后神经性疼痛
  • 批准号:
    7388160
  • 财政年份:
    2007
  • 资助金额:
    $ 44.26万
  • 项目类别:
Neuronal plasticity at remote sites causes neuropathic pain after SCI
远端部位的神经元可塑性导致 SCI 后神经性疼痛
  • 批准号:
    7274458
  • 财政年份:
    2007
  • 资助金额:
    $ 44.26万
  • 项目类别:

相似海外基金

Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 44.26万
  • 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
  • 批准号:
    494901
  • 财政年份:
    2023
  • 资助金额:
    $ 44.26万
  • 项目类别:
    Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
  • 批准号:
    10714537
  • 财政年份:
    2023
  • 资助金额:
    $ 44.26万
  • 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
  • 批准号:
    10588103
  • 财政年份:
    2023
  • 资助金额:
    $ 44.26万
  • 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
  • 批准号:
    22K09407
  • 财政年份:
    2022
  • 资助金额:
    $ 44.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
  • 批准号:
    21KK0287
  • 财政年份:
    2022
  • 资助金额:
    $ 44.26万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
  • 批准号:
    10357120
  • 财政年份:
    2022
  • 资助金额:
    $ 44.26万
  • 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
  • 批准号:
    21K08700
  • 财政年份:
    2021
  • 资助金额:
    $ 44.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
  • 批准号:
    437315
  • 财政年份:
    2020
  • 资助金额:
    $ 44.26万
  • 项目类别:
    Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
  • 批准号:
    435603
  • 财政年份:
    2020
  • 资助金额:
    $ 44.26万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了